Journey Medical Corporation DERM Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 66.2%+3.4pp | 62.8%-8.3pp | 71.1%+12.9pp | 58.2%+9.0pp | |
| Operating margin | -13.2%— | —— | -2.6%+34.7pp | -37.4%+17.9pp | |
| Net margin | -18.5%— | —— | -4.9%+35.4pp | -40.2%+29.5pp | |
| Returns | |||||
| Return on equity | -44%— | —— | -20.6%+79.7pp | -100.4%+67.7pp | |
| Return on invested capital | -28.2%— | —— | -32.8%— | —— | |
| Efficiency | |||||
| Asset turnover | 0.7×0.0× | 0.7×-0.2× | 0.9×+0.1× | 0.7×-0.1× | |
| Liquidity | |||||
| Current ratio | 1.8×+0.4× | 1.4×0.0× | 1.3×+0.2× | 1.2×-0.5× | |
| Leverage | |||||
| Debt-to-equity | 0.8×-0.5× | 1.2×+0.5× | 0.7×-0.5× | 1.2×+1.2× | |
| Per Share | |||||
| Book value per share | $1.30+32.4% | $0.98-12.0% | $1.12+15.2% | $0.97-76.5% | |
| Valuation | |||||
| Market capitalization | $194.94M+20.9% | $81.68M-26.6% | $111.31M+227% | $34.04M-63.5% | |
| Price / sales | 3×+0.2× | 1.5×0.0× | 1.4×+0.9× | 0.5×-1.0× | |
| Price / book | 6.3×-2.1× | 4.1×-1.4× | 5.5×+3.5× | 2×-0.2× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Journey Medical Corporation's profit margins?
- Journey Medical Corporation (DERM) runs a 65.4% gross margin and a -9.8% operating margin, with a -14.8% net margin.
- Where do Journey Medical Corporation's ratios come from?
- Every ratio is computed from Journey Medical Corporation's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
